Venter Institute Taps CLC Bio for Enterprise Bioinformatics Platform | GenomeWeb
NEW YORK (GenomeWeb News) - CLC Bio said today that the J. Craig Venter Institute has signed a multi-year site license for its full suite of bioinformatics products.
 
CLC said that JCVI will deploy its software across all of its research sites as an enterprise solution that will provide “a coherent integration layer and a standardized way of developing custom software and specialized algorithms.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.